Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase

International Journal of Neuropsychopharmacology

Volumn 16, Issue 5, 2013, Pages 1153-1163

  Loyens, Ellen ^a   De Bundel, Dimitri ^a   Demaegdt, Heidi ^a   Chai, Siew Yeen ^b   Vanderheyden, Patrick ^a   Michotte, Yvette ^a   Gard, Paul ^c   Smolders, Ilse ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Antidepressant; insulin regulated aminopeptidase; oxytocin

Indexed keywords

AMINOPEPTIDASE; INSULIN REGULATED AMINOPEPTIDASE; OXYTOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED SWIMMING TEST; GENE DELETION; IMMOBILIZATION; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL;

AGE FACTORS; AMINOPEPTIDASES; ANGIOTENSIN II; ANIMALS; ANTIDEPRESSIVE AGENTS; CELL MEMBRANE; CEREBRAL CORTEX; CYSTINYL AMINOPEPTIDASE; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; IMIPRAMINE; IMMOBILITY RESPONSE, TONIC; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; OXYTOCIN;

EID: 84877956087     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001149     Document Type: Article

References (35)

1. Albiston AL, Fernando RN, Yeatman HR, Burns P, et al. (2010). Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory. Neurobiology of Learning and Memory 93, 19-30.
2. Arletti R, Bertolini A (1987a). Influence of protease inhibitors on the antidepressant activity of oxytocin. Neuropeptides 10, 241-248.
3. Arletti R, Bertolini A (1987b). Oxytocin acts as an antidepressant in two animal models of depression. Life Sciences 41, 1725-1730.
4. Arletti R, Benelli A, Poggioli R, Luppi P, et al. (1995). Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin. Neuropeptides 29, 177-182.
5. Beyer CE, Dwyer JM, Platt BJ, Neal S, et al. (2010). Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation. Psychopharmacology (Berlin) 209, 303-311.
6. Burbach JP, Bohus B, Kovacs GL, Van Nispen JW, et al. (1983). Oxytocin is a precursor of potent behaviourally active neuropeptides. European Journal of Pharmacology 94, 125-131.
7. Burbach JP, de Kloet ER, De Wied D (1980). Oxytocin biotransformation in the rat limbic brain: characterization of peptidase activities and significance in the formation of oxytocin fragments. Brain Research 202, 401-414.
8. Burbach JP, Lebouille JL (1983). Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis. Journal of Biological Chemistry 258, 1487-1494.
9. Chai SY, Fernando R, Peck G, Ye SY, et al. (2004). The angiotensin IV/AT4 receptor. Cellular and Molecular Life Sciences 61, 2728-2737.
10. Chaviaras S, Mak P, Ralph D, Krishnan L, et al. (2010). Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology (Berlin) 210, 35-43.
11. Demaegdt H, Vanderheyden P, De Backer JP, Mosselmans S, et al. (2004). Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity. Biochemical Pharmacology 68, 885-892.
12. Ferguson JN, Aldag JM, Insel TR, Young LJ (2001). Oxytocin in the medial amygdala is essential for social recognition in the mouse. Journal of Neuroscience 21, 8278-8285.
13. Gard PR, Daw P, Mashhour ZS, Tran P (2007). Interactions of angiotensin IV and oxytocin on behaviour in mice. Journal of the Renin Angiotensin Aldosterone System 8, 133-138.
14. Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: structure, function, and regulation. Physiological Reviews 81, 629-683.
15. Keck ME, Hatzinger M, Wotjak CT, Landgraf R, et al. (2000). Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats. European Journal of Neuroscience 12, 1487-1494.
16. Klenerova V, Krejci I, Sida P, Hlinak Z, Hynie S (2009). Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field. Journal of Physiology and Pharmacology 60, 57-62.
17. Larcher A, Neculcea J, Breton C, Arslan A, et al. (1995). Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology 136, 5350-5356.
18. Lew RA, Mustafa T, Ye S, McDowall SG, et al. (2003). Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). Journal of Neurochemistry 86, 344-350.
19. Loyens E, Vermoesen K, Schallier A, Michotte Y, Smolders I (2012). Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors. Brain Research 1436, 43-50.
20. Lukaszuk A, Demaegdt H, Szemenyei E, Toth G, et al. (2008). Beta-homo-amino acid scan of angiotensin IV. Journal of Medicinal Chemistry 51, 2291-2296.
21. Matsumoto H, Nagasaka T, Hattori A, Rogi T, et al. (2001). Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. European Journal of Biochemistry 268, 3259-3266.
22. Matsumoto H, Rogi T, Yamashiro K, Kodama S, et al. (2000). Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. European Journal of Biochemistry 267, 46-52.
23. Melis MR, Stancampiano R, Fratta W, Argiolas A (1992). Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiology of Aging 13, 783-786.
24. Murata T, Murata E, Liu CX, Narita K, et al. (2000). Oxytocin receptor gene expression in rat uterus: regulation by ovarian steroids. Journal of Endocrinology 166, 45-52.
25. Murata T, Narita K, Honda K, Higuchi T (2003). Changes of receptor mRNAs for oxytocin and estrogen during the estrous cycle in rat uterus. Journal of Veterinary Medical Science 65, 707-712.
26. Neumann ID (2008). Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology 20, 858-865.
27. Ring RH, Malberg JE, Potestio L, Ping J, et al. (2006). Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berlin) 185, 218-225.
28. Ring RH, Schechter LE, Leonard SK, Dwyer JM, et al. (2010). Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology 58, 69-77.
29. Rotzinger S, Lovejoy DA, Tan LA (2009). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31, 736-756.
30. Slattery DA, Neumann ID (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 58, 56-61.
31. Stancampiano R, Argiolas A (1993). Proteolytic conversion of oxytocin in vivo after microinjection in the rat hippocampus. Peptides 14, 465-469.
32. Stancampiano R, Melis MR, Argiolas A (1991). Proteolytic conversion of oxytocin by brain synaptic membranes: role of aminopeptidases and endopeptidases. Peptides 12, 1119-1125.
33. Stancampiano R, Melis MR, Fratta W, Argiolas A (1994). Brain proteolysis of oxytocin in vitro and in vivo changes during aging in male rats. Neurobiology of Aging 15, 185-189.
34. Tsujimoto M, Mizutani S, Adachi H, Kimura M, et al. (1992). Identification of human placental leucine aminopeptidase as oxytocinase. Archives of Biochemistry and Biophysics 292, 388-392.
35. Wallis MG, Lankford MF, Keller SR (2007). Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. American Journal of Physiology 293, E1092-E1102.